{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:09:04Z","timestamp":1786705744275,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neuropharm.2015.02.024","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T04:56:30Z","timestamp":1425531390000},"page":"50-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Changes in the expression of genes encoding for mGlu4 and mGlu5 receptors and other regulators of the indirect pathway in acute mouse models of drug-induced parkinsonism"],"prefix":"10.1016","volume":"95","author":[{"given":"Milena","family":"Cannella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Motolese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.02.024_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuropharm.2012.05.026","article-title":"Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease","volume":"66","author":"Amalric","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib2","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00001756-199410270-00037","article-title":"Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys","volume":"5","author":"Asselin","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib3","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1523\/JNEUROSCI.3831-03.2004","article-title":"Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigrostriatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"24","author":"Battaglia","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib4","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1523\/JNEUROSCI.1595-06.2006","article-title":"Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"26","author":"Battaglia","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1471-4159.2006.04140.x","article-title":"Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders","volume":"100","author":"Battaglia","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-2236(03)00038-9","article-title":"Presymptomatic compensation in Parkinson's disease is not dopamine-mediated","volume":"26","author":"Bezard","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib7","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1523\/JNEUROSCI.5118-03.2004","article-title":"Glutamic acid decarboxylase 67 mRNA regulation in two globus pallidus neuron populations by dopamine and the subthalamic nucleus","volume":"24","author":"Billings","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib8","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jnc.12139","article-title":"Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and \u03b4 opioid systems","volume":"124","author":"Blume","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib9","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1212\/WNL.0b013e318198e0e9","article-title":"Mechanisms compensating for dopamine loss in early Parkinson disease","volume":"72","author":"Brotchie","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib10","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1523\/JNEUROSCI.17-12-04536.1997","article-title":"Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors","volume":"17","author":"Calabresi","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrn1763","article-title":"Metabotropic glutamate receptors in the basal ganglia motor circuit","volume":"6","author":"Conn","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2015.02.024_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0306-4522(01)00591-7","article-title":"Distribution and synaptic localisation of the metabotropic glutamate receptor 4(mGluR4) in the rodent CNS","volume":"110","author":"Corti","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2007.05.027","article-title":"Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1","volume":"54","author":"Crespo","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0014-2999(96)00761-3","article-title":"Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors","volume":"317","author":"DeBoer","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2015.02.024_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-0270(89)90150-7","article-title":"The use of c-fos as a metabolic marker in neuronal pathway tracing","volume":"29","author":"Dragunow","year":"1989","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nm.2183","article-title":"Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation","volume":"16","author":"Fallarino","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib17","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/01.WNL.0000095206.44418.5C","article-title":"Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease","author":"Fuxe","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib18","first-page":"196028","article-title":"Metabotropic glutamate receptors for Parkinson's disease therapy","volume":"2013","author":"Gasparini","year":"2013","journal-title":"Park. Dis."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib20","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-4159.1991.tb02027.x","article-title":"Preproenkephalin mRNA and methionine-enkephalin increase in mouse striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment","volume":"56","author":"Gudehithlu","year":"1991","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2004.11.008","article-title":"Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease","volume":"48","author":"Hallett","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Hekkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0306-4522(95)00120-8","article-title":"Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum","volume":"68","author":"Herrero","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2006.06.076","article-title":"Changes in mGlu5 receptor expression in the basal ganglia of reserpinised rats","volume":"545","author":"Ismayilova","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/187152709789824606","article-title":"Glutamate receptors as therapeutic targets for Parkinson's disease","volume":"8","author":"Johnson","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brainresbull.2013.07.001","article-title":"A2A receptor antagonists do not induce dyskinesias in drug-naive or L-dopa sensitized rats","volume":"98","author":"Jones","year":"2013","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1046-2023(02)00235-9","article-title":"Particle detection, number estimation, and feature measurement in gene transfer studies: optical fractionators stereology integrated with digital image processing and analysis","volume":"28","author":"King","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0197-0186(98)00023-0","article-title":"c-Fos as a transcription factor: a stressful (re)view from a functional map","volume":"33","author":"Kov\u00e1cs","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In\u00a0vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease","volume":"47","author":"Lee","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-3806(93)90026-7","article-title":"Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat","volume":"75","author":"Lipska","year":"1993","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib33","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1523\/JNEUROSCI.0299-07.2007","article-title":"Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease","volume":"27","author":"Lopez","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0304-3940(92)90589-Y","article-title":"Age-related loss of cannabinoid receptor binding sites and mRNA in the rat striatum","volume":"147","author":"Mailleux","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.neuron.2012.04.027","article-title":"Dichotomous organization of the external globus pallidus","volume":"74","author":"Mallet","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1196\/annals.1300.045","article-title":"Modulation of inhibitory transmission in the rat globus pallidus by activation of mGluR4","volume":"1003","author":"Marino","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.02.024_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/mol.113.085530","article-title":"Early life stress causes refractoriness to haloperidol-induced catalepsy","volume":"84","author":"Marrocco","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib38","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/sj.npp.1301558","article-title":"Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors","volume":"33","author":"Mart\u00edn","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuroscience.2005.09.005","article-title":"Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia","volume":"137","author":"M\u00e1ty\u00e1s","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.02.024_bib40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-3565(25)13418-6","article-title":"Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals","volume":"247","author":"Maura","year":"1988","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0028-3908(02)00090-4","article-title":"Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract","volume":"43","author":"Messenger","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib42","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1523\/JNEUROSCI.5310-08.2009","article-title":"Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons","volume":"29","author":"Meurers","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nbd.2013.09.013","article-title":"Development of allosteric modulators of GPCRs for treatment of CNS disorders","volume":"61","author":"Nickols","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib44","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuropharm.2010.10.022","article-title":"Metabotropic glutamate receptors: from the workbench to the bedside","volume":"60","author":"Nicoletti","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0306-4522(94)00606-6","article-title":"Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease","volume":"66","author":"Nisbet","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-4159.2010.06635.x","article-title":"Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys","volume":"113","author":"Ouattara","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib47","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1523\/JNEUROSCI.16-20-06364.1996","article-title":"Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor","volume":"16","author":"Pekhletski","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nbd.2006.07.006","article-title":"Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia","volume":"24","author":"Pisani","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib49","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0306-4522(98)00370-4","article-title":"Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats","volume":"89","author":"Rodr\u00edguez-Puertas","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuroimage.2008.04.170","article-title":"Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates","volume":"42","author":"Sanchez-Pernaute","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0306-4522(91)90152-E","article-title":"A\u00a0GABA immunocytochemical study of rat motor thalamus: light and electron microscopic observations","volume":"42","author":"Sawyer","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib52","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ana.21204","article-title":"Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study","volume":"62","author":"Sossi","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0306-4522(97)00597-6","article-title":"Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum","volume":"85","author":"Szabo","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib54","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.410350421","article-title":"Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons","volume":"35","author":"Uhl","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib55","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1523\/JNEUROSCI.23-18-07218.2003","article-title":"Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse","volume":"23","author":"Valenti","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib56","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1124\/jpet.104.080481","article-title":"Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons","volume":"313","author":"Valenti","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fphar.2012.00021","article-title":"CB1 Cannabinoid receptor expression in the striatum: association with corticostriatal circuits and developmental regulation","volume":"3","author":"Van Waes","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib58","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1152\/jn.1997.77.2.1003","article-title":"D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway","volume":"77","author":"Yan","year":"1997","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1523\/JNEUROSCI.1129-13.2014","article-title":"Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS","volume":"34","author":"Yin","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.02.024_bib60","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000138140","article-title":"Pharmacokinetics and effects of haloperidol in the isolated mouse","volume":"31","author":"Zetler","year":"1985","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2015.02.024_bib61","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archneur.1984.04050190062015","article-title":"Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism","volume":"41","author":"Zigmond","year":"1984","journal-title":"Arch. Neurol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T18:47:48Z","timestamp":1747766868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":61,"alternative-id":["S0028390815000805"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.024","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in the expression of genes encoding for mGlu4 and mGlu5 receptors and other regulators of the indirect pathway in acute mouse models of drug-induced parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}